298 related articles for article (PubMed ID: 32627044)
1. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathological and prognostic significances of IGF-1R and Livin expression in patients with colorectal cancer.
Zhang Z; Zhang Y; Lao S; Qiu J; Pan Z; Feng X
BMC Cancer; 2022 Aug; 22(1):855. PubMed ID: 35931997
[TBL] [Abstract][Full Text] [Related]
3. C8orf48 inhibits the tumorigenesis of colorectal cancer by regulating the MAPK signaling pathway.
Lei L; An G; Zhu Z; Liu S; Fu Y; Zeng X; Cao Q; Yan B
Life Sci; 2021 Feb; 266():118872. PubMed ID: 33309715
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1.
Zhang J; Wang Y; Hou S; Chi X; Ding D; Xue M; Zhang M; Wang J; Shuai J; Sun H; Gao Q; Kang C
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666541
[TBL] [Abstract][Full Text] [Related]
5. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
Yong L; YuFeng Z; Guang B
Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
[TBL] [Abstract][Full Text] [Related]
6. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
7. TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer.
Chen Y; Wang J; Wang D; Kang T; Du J; Yan Z; Chen M
J Gene Med; 2020 Feb; 22(2):e3152. PubMed ID: 31830337
[TBL] [Abstract][Full Text] [Related]
8. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
10. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
11. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
[TBL] [Abstract][Full Text] [Related]
12. High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype.
Huang Y; Wang G; Zhao C; Geng R; Zhang S; Wang W; Chen J; Liu H; Wang X
Dis Markers; 2019; 2019():5231269. PubMed ID: 30956730
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
14. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
[TBL] [Abstract][Full Text] [Related]
15. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
16. Expression of TUSC3 and its prognostic significance in colorectal cancer.
Zhu YF; Dong M
Pathol Res Pract; 2018 Sep; 214(9):1497-1503. PubMed ID: 30115537
[TBL] [Abstract][Full Text] [Related]
17. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
[TBL] [Abstract][Full Text] [Related]
18. Upregulated NLGN1 predicts poor survival in colorectal cancer.
Yu Q; Wang X; Yang Y; Chi P; Huang J; Qiu S; Zheng X; Chen X
BMC Cancer; 2021 Aug; 21(1):884. PubMed ID: 34340665
[TBL] [Abstract][Full Text] [Related]
19. Cardiac tropoini T (TNNT2) plays a potential oncogenic role in colorectal carcinogenesis.
Liu Y; Meng Z; Niu J; Tian L; Chen Y; Meng Q; Liu Y; Zhou Z
Cancer Cell Int; 2023 Jul; 23(1):146. PubMed ID: 37481519
[TBL] [Abstract][Full Text] [Related]
20. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.
Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB
BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]